Evidence map›Paper›PMID 30075321›Full record

ArticleActa biomaterialia2018

Incorporation of fast dissolving glucose porogens and poly(lactic-co-glycolic acid) microparticles within calcium phosphate cements for bone tissue regeneration.

Brandon T Smith, Alexander Lu, Emma Watson, Marco Santoro, Anthony J Melchiorri, Eline C Grosfeld, Jeroen J J P van den Beucken, John A Jansen, David W Scott, John P Fisher and 1 more

Open access · greenAbstract read
In one paragraph

Article in Acta biomaterialia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Brandon T SmithDepartment of Bioengineering, Rice University, 6500 Main Street, Houston, TX 77030, USA; Biomaterials Lab, Rice University, 6500 Main Street, Houston, TX 77030, USA; NIH / NIBIB Center for Engineering Complex Tissues, USA; Medical Scientist Training Program, Baylor College of Medicine, Houston, TX, USA.
Alexander LuDepartment of Bioengineering, Rice University, 6500 Main Street, Houston, TX 77030, USA.
Emma WatsonDepartment of Bioengineering, Rice University, 6500 Main Street, Houston, TX 77030, USA; Biomaterials Lab, Rice University, 6500 Main Street, Houston, TX 77030, USA; NIH / NIBIB Center for Engineering Complex Tissues, USA; Medical Scientist Training Program, Baylor College of Medicine, Houston, TX, USA.
Marco SantoroNIH / NIBIB Center for Engineering Complex Tissues, USA; Fischell Department of Bioengineering, University of Maryland, 8278 Paint Branch Dr, College Park, MD 20742, USA.
Anthony J MelchiorriBiomaterials Lab, Rice University, 6500 Main Street, Houston, TX 77030, USA; NIH / NIBIB Center for Engineering Complex Tissues, USA.
Eline C GrosfeldDepartment of Biomaterials, Radboudumc, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.
Jeroen J J P van den BeuckenDepartment of Biomaterials, Radboudumc, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.
John A JansenDepartment of Biomaterials, Radboudumc, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.
David W ScottDepartment of Statistics, Rice University, 6500 Main Street, Houston, TX 77030, USA.
John P FisherNIH / NIBIB Center for Engineering Complex Tissues, USA; Fischell Department of Bioengineering, University of Maryland, 8278 Paint Branch Dr, College Park, MD 20742, USA.
Antonios G MikosDepartment of Bioengineering, Rice University, 6500 Main Street, Houston, TX 77030, USA; Biomaterials Lab, Rice University, 6500 Main Street, Houston, TX 77030, USA; NIH / NIBIB Center for Engineering Complex Tissues, USA. Electronic address: mikos@rice.edu.
Rice University · USRadboud University Nijmegen · NLUniversity of Maryland, College Park · USRadboud University Medical Center · NL

Funding

Training and Dissemination CoreP41EB023833 · NIBIB · UNIV OF MARYLAND, COLLEGE PARK · PI MIKOS, ANTONIOS G. · 2017 to 2021
$6.2M
Rapidly-Degrading Calcium Phosphate Cements for Orthopedic Tissue Engineering.F30AR071258 · NIAMS · RICE UNIVERSITY · PI SMITH, BRANDON · 2017 to 2020
$168k
"A Two-Stage High-Fidelity, Anti-Infective Approach to Craniofacial Repair in Novel Ovine Model"F31DE027586 · NIDCR · RICE UNIVERSITY · PI WATSON, EMMA · 2017 to 2019
$134k
NIAMS NIH HHS F30 AR071258NIBIB NIH HHS P41 EB023833NIDCR NIH HHS F31 DE027586
6 · The paper itself

Abstract

This study investigated the effects of incorporating glucose microparticles (GMPs) and poly(lactic-co-glycolic acid) microparticles (PLGA MPs) within a calcium phosphate cement on the cement's handling, physicochemical properties, and the respective pore formation. Composites were fabricated with two different weight fractions of GMPs (10 and 20 wt%) and two different weight fractions of PLGA MPs (10 and 20 wt%). Samples were assayed for porosity, pore morphology, and compressive mechanical properties. An in vitro degradation study was also conducted. Samples were exposed to a physiological solution for 3 days, 4 wks, and 8 wks in order to understand how the inclusion of GMPs and PLGA MPs affects the composite's porosity and mass loss over time. GMPs and PLGA MPs were both successfully incorporated within the composites and all formulations showed an initial setting time that is appropriate for clinical applications. Through a main effects analysis, we observed that the incorporation of GMPs had a significant effect on the overall porosity, mean pore size, mode pore size, and in vitro degradation rate of PLGA MPs as early as after 3 days (p < 0.05). After 4 wks and 8 wks, these same properties were affected by the inclusion of both types of MPs (p < 0.05). Advanced polymer chromatography confirmed that the degradation of PLGA MPs coincided with an increase in composite porosity, mean pore size, and mode pore size. Finally, it was observed that the inclusion of GMPs slowed the degradation of PLGA MPs in vitro and reduced the solution acidity due to PLGA degradation products. Our results suggest that the dual inclusion of GMPs and PLGA MPs is a valuable approach for the generation of early macropores, while also mitigating the effect of acidic degradation products from PLGA MPs on their degradation kinetics. STATEMENT OF SIGNIFICANCE: A multitude of strategies and techniques have been investigated for the introduction of macropores with calcium phosphate cements (CPC). However, many of these strategies take several weeks to months to generate a maximal porosity or the degradation products of the porogen can trigger a localized inflammatory response in vivo. As such, it was hypothesized that the fast dissolution of glucose microparticles (GMPs) in a CPC composite also incorporating poly(lactic-co-glycolic acid) (PLGA) microparticles (MPs) will create an initial macroporosity and increase the surface area within the CPC, thus enhancing the diffusion of PLGA degradation products and preventing a significant decrease in pH. Furthermore, as PLGA degradation occurs over several weeks to months, additional macroporosity will be generated at later time points within CPCs. The results offer a new method for generating macroporosity in a multimodal fashion that also mitigates the effects of acidic degradation products.

Indexed as

MicrospheresBone and BonesBone CementsBone RegenerationCalcium PhosphatesCompressive StrengthGlucoseHydrogen-Ion ConcentrationModels, StatisticalMolecular WeightPolylactic Acid-Polyglycolic Acid CopolymerPorositySolubilityTime FactorsX-Ray DiffractionBone Cementscalcium phosphateCalcium PhosphatesGlucosePolylactic Acid-Polyglycolic Acid CopolymerCalcium phosphate cementGlucoseMacroporosityPoly(lactic-co-glycolic acid)Porogen

Identifiers

PMID30075321
PMCPMC6650161
OpenAlexW2887697459

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.